Benzinga | Jan 11, 2022 04:22PM EST

UPDATE: Centers For Medicare, Medicaid Services Listing On Alzheimer's Treatment Shows CMS 'proposes to cover FDA approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer's disease under Coverage with Evidence Development'

https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=Y&ncaid=305&ncacaldoctype=all&status=all&sortBy=status&bc=17